Table 1 Criteria for the withdrawal of anticoagulation treatment among patients with cancer-associated thrombosis

From: D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis

•At least 3 months of anticoagulation treatment

•Ultrasound-confirmed absence of residual venous thrombosis in the lower limbs (defined as <0.3 cm)

•Absence of cancer progression or signs that suggests non-stability of the disease

•Absence of lupus anticoagulant (testing repeated twice at a 12-week interval)

•Absence of suspected chronic thromboembolic pulmonary hypertension

•Absence of any circumstance favouring treatment maintenance based on the clinician’s discretion

•Informed consent received from the patient

Back to article page